ERCC excision repair 6 like 2 (ERCC6L2) gene encodes for different helicase-like protein members of the Snf2 family involved in transcription-coupled nucleotide excision repair and in cell proliferation. Germline homozygous mutations in children and adults predispose to a peculiar bone marrow failure phenotype characterized by mild hematological alterations with a high risk of developing acute myeloid leukemia. The outcome for patients with leukemia progression is dismal while patients undergoing hematopoietic stem cell transplantation in the early stage have better outcomes. The ERCC6L2-related hematological disease presents a high penetrance, posing important questions regarding the treatment strategies and possible preemptive approaches. This review describes the biological function of ERCC6L2 and the clinical manifestations of the associated disease, trying to focus on the unsolved clinical questions.

Baccelli, F., Leardini, D., Cerasi, S., Messelodi, D., Bertuccio, S.N., Masetti, R. (2023). ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. ANNALS OF HEMATOLOGY, 102(4), 699-705 [10.1007/s00277-023-05128-2].

ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution

Baccelli, Francesco;Leardini, Davide
;
Cerasi, Sara;Messelodi, Daria;Bertuccio, Salvatore Nicola;Masetti, Riccardo
2023

Abstract

ERCC excision repair 6 like 2 (ERCC6L2) gene encodes for different helicase-like protein members of the Snf2 family involved in transcription-coupled nucleotide excision repair and in cell proliferation. Germline homozygous mutations in children and adults predispose to a peculiar bone marrow failure phenotype characterized by mild hematological alterations with a high risk of developing acute myeloid leukemia. The outcome for patients with leukemia progression is dismal while patients undergoing hematopoietic stem cell transplantation in the early stage have better outcomes. The ERCC6L2-related hematological disease presents a high penetrance, posing important questions regarding the treatment strategies and possible preemptive approaches. This review describes the biological function of ERCC6L2 and the clinical manifestations of the associated disease, trying to focus on the unsolved clinical questions.
2023
Baccelli, F., Leardini, D., Cerasi, S., Messelodi, D., Bertuccio, S.N., Masetti, R. (2023). ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. ANNALS OF HEMATOLOGY, 102(4), 699-705 [10.1007/s00277-023-05128-2].
Baccelli, Francesco; Leardini, Davide; Cerasi, Sara; Messelodi, Daria; Bertuccio, Salvatore Nicola; Masetti, Riccardo
File in questo prodotto:
File Dimensione Formato  
s00277-023-05128-2.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 936.99 kB
Formato Adobe PDF
936.99 kB Adobe PDF Visualizza/Apri
5128.zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 59.43 kB
Formato Zip File
59.43 kB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/942536
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact